| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.047 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |